JPWO2020027150A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020027150A5
JPWO2020027150A5 JP2020534675A JP2020534675A JPWO2020027150A5 JP WO2020027150 A5 JPWO2020027150 A5 JP WO2020027150A5 JP 2020534675 A JP2020534675 A JP 2020534675A JP 2020534675 A JP2020534675 A JP 2020534675A JP WO2020027150 A5 JPWO2020027150 A5 JP WO2020027150A5
Authority
JP
Japan
Prior art keywords
phenyl
enoxy
benzenesulfonamide
penta
propionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020534675A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020027150A1 (ja
JP7306392B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/029883 external-priority patent/WO2020027150A1/ja
Publication of JPWO2020027150A1 publication Critical patent/JPWO2020027150A1/ja
Publication of JPWO2020027150A5 publication Critical patent/JPWO2020027150A5/ja
Priority to JP2023100088A priority Critical patent/JP7632523B2/ja
Application granted granted Critical
Publication of JP7306392B2 publication Critical patent/JP7306392B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020534675A 2018-07-31 2019-07-30 ベンゼン誘導体 Active JP7306392B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023100088A JP7632523B2 (ja) 2018-07-31 2023-06-19 ベンゼン誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018143024 2018-07-31
JP2018143024 2018-07-31
PCT/JP2019/029883 WO2020027150A1 (ja) 2018-07-31 2019-07-30 ベンゼン誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023100088A Division JP7632523B2 (ja) 2018-07-31 2023-06-19 ベンゼン誘導体

Publications (3)

Publication Number Publication Date
JPWO2020027150A1 JPWO2020027150A1 (ja) 2021-08-12
JPWO2020027150A5 true JPWO2020027150A5 (https=) 2022-06-02
JP7306392B2 JP7306392B2 (ja) 2023-07-11

Family

ID=69232258

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020534675A Active JP7306392B2 (ja) 2018-07-31 2019-07-30 ベンゼン誘導体
JP2023100088A Active JP7632523B2 (ja) 2018-07-31 2023-06-19 ベンゼン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023100088A Active JP7632523B2 (ja) 2018-07-31 2023-06-19 ベンゼン誘導体

Country Status (14)

Country Link
US (3) US11261154B2 (https=)
EP (1) EP3831810A4 (https=)
JP (2) JP7306392B2 (https=)
KR (1) KR102799419B1 (https=)
CN (1) CN112513011B (https=)
AU (1) AU2019313082B2 (https=)
CA (1) CA3108046A1 (https=)
IL (1) IL280453B2 (https=)
MX (2) MX2021001110A (https=)
PH (1) PH12021550207A1 (https=)
SG (1) SG11202101033YA (https=)
TW (1) TWI881947B (https=)
WO (1) WO2020027150A1 (https=)
ZA (1) ZA202100679B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020027150A1 (ja) * 2018-07-31 2020-02-06 小野薬品工業株式会社 ベンゼン誘導体
KR20220132537A (ko) 2020-01-29 2022-09-30 오노 야꾸힝 고교 가부시키가이샤 벤젠 유도체의 신규 결정형
WO2023111996A1 (en) 2021-12-17 2023-06-22 Reglagene Holding, Inc. Compositions and methods of making and using small molecules in the treatment of cancer
US12215102B2 (en) 2023-02-28 2025-02-04 Reglagene, Inc. Compositions and methods for making and using small molecules for tubulin-targeted therapy in the treatment of cancers and related conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453443A (en) 1994-07-20 1995-09-26 Merck Frosst Canada, Inc. Bis(aryloxy)alkanes as inhibitors of phospholipase A2 enzymes
TW523506B (en) 1996-12-18 2003-03-11 Ono Pharmaceutical Co Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
CN101284773A (zh) * 2001-08-09 2008-10-15 小野药品工业株式会社 羧酸衍生物及以它为活性成分的药剂
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
EP1874318A2 (en) * 2005-04-19 2008-01-09 Merck & Co., Inc. N-alkyl-azacycloalkyl nmda/nr2b antagonists
RU2420316C2 (ru) * 2005-06-03 2011-06-10 Оно Фармасьютикал Ко., Лтд. Агент для регенерации и/или защиты нервов
UA99927C2 (uk) * 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
LU92852B1 (en) * 2015-10-20 2017-05-02 Athanasios Spathis NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease
CN105622488B (zh) * 2016-04-01 2018-03-20 南阳师范学院 一种4‑环胺烷氧基‑3‑甲氧基肉桂酸酯类化合物、制备方法及其用途
WO2020027150A1 (ja) * 2018-07-31 2020-02-06 小野薬品工業株式会社 ベンゼン誘導体

Similar Documents

Publication Publication Date Title
JPWO2020027150A5 (https=)
JP2018024670A5 (https=)
JP2008506632A5 (https=)
JP2010507641A5 (https=)
JP2015199738A5 (https=)
JP2023526975A5 (https=)
JP2016153424A5 (https=)
JP2024026077A5 (https=)
JP2022185040A5 (https=)
JP2006526031A5 (https=)
JP2009535462A5 (https=)
JP2019089762A5 (https=)
JP2023534131A5 (https=)
JP2018150298A5 (https=)
JP2009502793A5 (https=)
JP2007269812A5 (https=)
JP2007533752A5 (https=)
JP2011134884A5 (https=)
JP2003335776A5 (https=)
JP2023116477A5 (https=)
JP2022064180A5 (https=)
JP2022518056A5 (https=)
IL276709B2 (en) Sensor unit
JP2023524547A5 (https=)
JP2010535829A5 (https=)